Switzerland· 67375005
Zebinix 800 mg, comprimés
A eslicarbazepine product containing eslicarbazepini acetas, registered in Switzerland by Bial SA and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Eslicarbazepine is registered in 16 of 19 countries.
Countries holding a registration under ATC N03AF04 (eslicarbazepine), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 10 of them publish a price we can compare per daily dose
Eslicarbazepine · ATC N03AF04
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of eslicarbazepine costs, country by country.
Normalised to the WHO defined daily dose (0.8 g), the median price runs from $2.32 in Italy to $4.08 in Switzerland — a ×1.8 gap.
- Switzerland: $4.08 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Eslicarbazepine · price per daily dose (0.8 g)
USD · FX 28 Sept 2026
- CH Switzerland$4.08
- ES Spain$3.49
- IT Italy$2.32
The record
At a glance
Swissmedic (Switzerland)- Active substance
- eslicarbazepini acetas
- Manufacturer
- Bial SA
- Country
- Switzerland (CH)
- ATC code
- N03AF04
- ATC class
- Eslicarbazepine
- Defined daily dose
- 0.8 g, O
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin768067375005690 StkCHF 271.5
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
188 interactions on record for eslicarbazepine.
Graded by severity as the source publishes them — 17 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Eslicarbazepine · interactions on record
188 records
- 17 severe
- 166 moderate
- 5 minor
Most severe, free to view
- Levonorgestrel and ethinylestradiolG03AA07severe
- Desogestrel and ethinylestradiolG03AA09severe
- Drospirenone and ethinylestradiolG03AA12severe
- EthinylestradiolG03CA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Eslicarbazepine in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaESLIBONG.L. Pharma GmbH, Lannach
- SpainARUPSAN 800 MG COMPRIMIDOS EFGAccord Healthcare S.L.U.
- United KingdomArupsan 800mg tabletsAccord-UK Ltd
- United StatesAptiomSumitomo Pharma America, Inc.
- FinlandZebinixBial Portela & C, S.A.
- ItalyARUPSANACCORD HEALTHCARE SLU
- NorwayZebinixAbacus Medicine A/S
- IcelandESLICARBAZEPIN DOCDOC Generici S.r.l.
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Austria · Eslibon
- Bulgaria · Еслибон
- Cyprus · Esran
- Czechia · Eslibon, Eslikarbazepin Neuraxpharm
- Germany · Eslibon, Eslicarbazepin Al
- Denmark · Arupsan, Eslicarbazepinacetat "stada"
- Spain · Arupsan, Bixcar
- France · Eslicarbazepine 800, Eslicarbazepine Arrow
- United Kingdom (Northern Ireland) · Arupsan, Eslicarbazepine Amarox
- Greece · Esran
- Hungary · Eslicarbazepine 800
- Iceland · Eslicarbazepin, Eslicarbazepine Acetate Stada
- Italy · Arupsan, Eslicarbazepina Acetato Aurobindo
- Liechtenstein · Zebinix
- Malta · Esran
- Netherlands · Eslibon
- Norway · Zebinix
- Poland · Eslibon
- Portugal · Acetato De Eslicarbazepina Alter, Acetato De Eslicarbazepina Aristo
- Sweden · Arupsan
- Slovakia · Eslibon
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/629badc0-9e0b-40b7-8429-34fc1df8a4bd GET /v1/drugs/629badc0-9e0b-40b7-8429-34fc1df8a4bd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "eslicarbazepini acetas 800 mg",
"valid_from": "2022-09-01",
"limitations": null,
"galenic_form": "Tabl 800 mg",
"therapeutic_area": null,
"sl_inclusion_date": "2022-09-01",
"self_retention_pct": 10
}See everything about eslicarbazepine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.